involve multiple organs such as sinuses, lungs, skin, nervous system, heart, gastrointestinal tract, kidneys, etc. The vast majority of patients have asthma and/or allergic rhinitis .
For chronic cough!
Time of Update: 2022-05-28
Recently, the official website of CDE showed that Hengrui Medicine’s clinical trial application for HRS-2261 tablets was approved for the treatment of chronic cough .
Chinese patent medicines "seize" the retail market of cough medicines, and many varieties grow against the trend
Time of Update: 2022-05-24
In 2020, the sales growth of physical pharmacies in key cities and the top 5 varieties of cough medicines Data source: Minet.
Sneezing, Coughing, and Itchy Eyes: How to Cope with Allergies in the Spring
Time of Update: 2022-04-25
>sneeze>cough>itchy eyes and nose>dark circles>How to Reduce Exposure to Allergy Triggers
The State Food and Drug Administration revises the drug insert of the children's phlegm-relieving and cough-relieving preparations
Time of Update: 2022-04-23
The item [adverse reactions] should include: Monitoring data show that children's anti-phlegm and anti-cough preparations have vomiting, nausea, diarrhea, abdominal pain, rash, itching, sweating, dizziness, Headache, allergic reaction and other adverse reaction reports .
Cough mouse model
Time of Update: 2022-04-20
Therefore, the Osaka University research team aimed to identify the mechanisms that control cough in order to facilitate the development of treatments for those with active disease .
Can rock sugar Sydney moisten the lungs and relieve cough?
Time of Update: 2022-04-16
Of course, because pears have a lot of water, eating pears is really good for replenishing water, and it can also relieve symptoms such as throat discomfort and cough caused by dryness .
Innovative drug for chronic cough: the world's first selective P2X3 receptor antagonist significantly reduces cough frequency!
Time of Update: 2022-02-17
Lyfnua is an oral, selective P2X3 receptor antagonist indicated for the treatment of refractory chronic cough (RCC) or unexplained chronic cough (UCC) in adults .
Reduce cough frequency by 34%, innovative P2X3 receptor antagonist Phase 2 clinical results are positive
Time of Update: 2021-12-29
On December 13, 2021, Bellus Health announced that a phase 2b clinical trial of the selective oral P2X3 receptor antagonist BLU-5937 has obtained positive results .
What about coughing and shortness of breath?
Time of Update: 2021-12-07
(WBC) 7. 37×109/L, hemoglobin (HGB) 132g/L, platelet count (PLT) 309×109/L, rheumatoid factor (RF) 21. 9 IU/ml; C-reactive protein (CRP) ) 35. 3 mg/L, erythrocyte sedimentation rate (ESR) 46 mm/h; immunoglobulin IgG 21 g/L
Coughing and dyspnea are getting worse, and finally diagnosed as a rare syndrome?
Time of Update: 2021-11-15
ILD is the main manifestation of the lungs in patients with ASS.
Early diagnosis and timely treatment will significantly improve the prognosis of ASS patients .
Use this kind of antibiotics for lung infections, never use this kind of cough medicine!
Time of Update: 2021-10-23
2 When using levofloxacin to fight infection, you should not use antipyretics and occasionally see some magical instructions from some manufacturers: levofloxacin should be avoided in combination with non-steroidal anti-inflammatory drugs!
The billion-dollar chronic cough market is vacant, and P2X3 antagonists are here
Time of Update: 2021-10-22
receptor antagonist, currently mainly used in the treatment of refractory chronic cough (RCC) adult patients in the respiratory field and endometriosis in the pain field and other complex internal organs Pain patients
The multi-billion-dollar chronic cough market is vacant with P2X3 antagonists coming
Time of Update: 2021-10-22
ineffective. There are no approved drugs for the treatment of chronic cough; China’s national multi-center chronic cough etiology survey shows that the proportion of chronic cough patients with unexplained cough is about 8. 4%
The common "cough virus" actually manipulates host immune genes
Time of Update: 2021-10-21
The viral protein NS1 (green) is found in the nucleus (blue) of human respiratory cilia cells (red shows cilia) infected with respiratory syncytial virus (RSV) .
Sino-U.S. Double News: China Biopharmaceuticals declares P2X3 receptor antagonist to treat chronic cough
Time of Update: 2021-10-19
In addition, P2X3 receptors are also specifically expressed on primary sensory neurons, and their high expression and activation can lead to hyperalgesia in chronic pain model animals, and changes in physiological and pathological pain regulation .
Thorax: The risk and impact of chronic cough in obese individuals in the general population
Time of Update: 2021-10-10
diabetesIt can be seen that there is a dose-response relationship between BMI and chronic cough , and the risk of chronic cough in obese individuals is 2-3 times higher than that of the general population .
Can monoammonium glycyrrhizinate S treat cough?
Time of Update: 2021-08-11
In addition, it can also be used for The treatment of oral ulcers, hepatitis B and gastric ulcers also has a strong detoxification effect against a variety of toxins.
Thorax: Risk and Influencing Factors of Chronic Cough in Obese Individuals
Time of Update: 2021-08-01
Researchers aimed to investigate the risk and influencing factors of chronic cough in obese individuals in the general population .
Many children cough and nosebleed after painting the exterior wall of a kindergarten in Shenzhen
Time of Update: 2021-08-01
of Longhua New District had different symptoms such as nosebleeds, cough, fever, vomiting, and uncomfortable eyes. > Global Coatings Network News:
